Fmoc-Leu-Pro-OH contains a leucine residue linked to proline with a free carboxylic acid at the C-terminus, forming a peptide-like intermediate in which the N-terminus is protected by an Fmoc (9-fluorenylmethoxycarbonyl) group. The molecule bears an amino functionality masked as the Fmoc carbamate, a secondary amine within the proline ring, and a side chain on leucine characterized by an isobutyl group, with stereochemistry not specified in the product name. Fmoc-Leu-Pro-OH is used in stepwise peptide synthesis, where the Fmoc protecting group supports controlled N-deprotection and subsequent coupling to build longer peptide chains under chemoselective conditions.
Fmoc-Leu-Pro-OH is a dipeptide building block combining an N-(9H-fluoren-9-ylmethoxycarbonyl) protected leucine residue with a proline carboxylic acid, forming a chiral, conformationally constrained amino acid derivative. The molecule contains an Fmoc-protected secondary amine on the leucine nitrogen, a free carboxylic acid at the proline terminus, and a cyclic pyrrolidine side chain that influences backbone dihedral angles during peptide assembly. The leucine residue contributes a hydrophobic isobutyl side chain, while the proline ring provides a stereodefined secondary amide environment that can affect coupling efficiency and subsequent deprotection behavior. As a protected peptide intermediate, Fmoc-Leu-Pro-OH is designed for compatibility with standard peptide coupling chemistry and downstream transformations involving N-terminal deprotection and C-terminal functional group manipulation.
1. Fmoc Solid-Phase Peptide Synthesis
Fmoc-Leu-Pro-OH is applied in Fmoc-based solid-phase peptide synthesis workflows where the Fmoc group enables controlled N-terminal deprotection and subsequent amide bond formation. The protected leucine nitrogen and the proline carboxylic acid define a peptide-ready segment that participates directly in chain elongation through carboxyl activation and nucleophilic amide formation. The proline pyrrolidine ring imposes conformational constraints that can be leveraged to construct peptides with defined turn propensity and reduced conformational freedom. Incorporation of this dipeptide segment supports the preparation of longer peptide sequences for research-grade library synthesis and method development in peptide construction.
2. Protected Dipeptide Intermediate
Fmoc-Leu-Pro-OH serves as a protected amino acid derivative intermediate for stepwise synthesis of peptide analogs and peptidomimetic scaffolds. The Fmoc carbamate protects the leucine amine from premature coupling, while the terminal carboxylic acid at proline remains available for selective activation under standard peptide coupling conditions. The presence of both a protected N-terminus and an unprotected C-terminus aligns with protecting-group strategies that separate orthogonal reactivity during multistep assembly, including iterative chain building and late-stage functionalization. Downstream use includes preparation of sequence-defined fragments for fragment condensation, convergent peptide synthesis, and intermediate supply for manufacturing-scale peptide workflows.
3. Conformationally Constrained Peptidomimetics
Fmoc-Leu-Pro-OH is utilized in peptidomimetic and structure-guided scaffold design where the proline residue contributes stereochemical rigidity and altered amide bond accessibility. The cyclic side chain and the leucine hydrophobic side chain together can help tune local hydrophobicity and backbone geometry, supporting SAR studies that probe how sequence context affects binding conformations. Fmoc-Leu-Pro-OH can be incorporated into peptide analogs where N-terminal deprotection enables controlled coupling to diverse partners, including modified amino acids, noncanonical residues, or functionalized linkers. The resulting analogs can then be used as biochemical research tools to evaluate structure-function relationships and to generate chemically defined leads for medicinal chemistry optimization.
4. Bioconjugation Linker Building
Fmoc-Leu-Pro-OH is applied in chemical biology and bioconjugation chemistry as a dipeptide-derived linker component that can be positioned between biomolecular recognition elements and reactive handles. The Fmoc-protected amine supports controlled unmasking to enable coupling to activated biomolecule-reactive groups, while the proline carboxyl functionality can be transformed into amide, ester, or activated derivatives for conjugation strategies. The leucine hydrophobic segment and proline ring can influence linker conformation and reduce unwanted flexibility, which may improve reproducibility of conjugate properties across synthesis batches. Downstream derivatization enables construction of labeled peptides, affinity probes, and chemically defined conjugates used in molecular recognition assays and analytical method development.
5. Pharmaceutical Process Chemistry
Fmoc-Leu-Pro-OH is relevant to pharmaceutical manufacturing and process chemistry for producing sequence-defined peptide intermediates under scalable, protecting-group compatible conditions. The Fmoc carbamate and terminal carboxylic acid provide a predictable reactivity pattern for controlled deprotection and coupling steps, supporting robust route design for peptide fragment preparation. The stereodefined leucine and proline residues reduce ambiguity in intermediate identity for downstream purification and analytical characterization, which is important for process reproducibility. Industrial utility extends to fine chemical synthesis of peptide-based building blocks, including intermediate supply for larger peptide API or peptide material manufacturing pipelines.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More